A Case of Henoch-Shönlein Purpura Caused by Rifampin

Rifampin is one of the first line drugs for treating tuberculosis, but it might be associated with serious adverse effects, including renal failure. We report here on a case of a 57-year-old patient who developed Henoch-Shönlein purpura during antituberculosis therapy that included rifampin. The patient converted to negative on the AFB smear for tuberculosis two weeks after the initial administration of antituberculosis medication. After treatment for 60 days, this patient was diagnosed with Henoch-Shönlein purpura by the purpura lesion on the lower legs, the leukocytoclastic vasculitis, the renal impairment and the pathological examination. After stopping rifampin, the skin lesions disappeared in about 10 days and his renal function gradually improved. This case study showed that Henoch-Schönlein purpura can be caused by rifampin during antituberculosis therapy and we recommend that the use of rifampin should be restrained when clinical symptoms of Henoch-Shönlein purpura are observed.

keywords: Acute renal failure, Henoch-Shönlein purpura, Rifampin, Tuberoculosis, Acute renal failure, Henoch-Shönlein purpura, Rifampin, Tuberoculosis

Reference

1.Yoshioka K, Satake N, Kasamatsu Y, Nakamura Y, Shikata N. Rapidly progressive glomerulonephritis due to rifampicin therapy. Nephron 2002;90:116-8.

2.Gabow PA, Lacher JW, Neff TA. Tubulointerstitial and glomerular nephritis associated with rifampin. Report of a case. JAMA 1976;235:2517-8.

3.Massry SG, Glassock RJ. Henoch-Schönlein purpura: clinical feature, etiology, and pathogenesis, laboratory finding, pathology, natural history, management, and transplantation. Massary and Glassock's text book of nephrology. 4th ed. Philadelphia: Lippincott Wiliams & Wilkins; 2001. p. 804-8.

4.Grosset J, Leventis S. Adverse effects of rifampin. Rev Infect Dis 1983;5:S440-50.

5.Campese VM, Marzullo F, Schena FP, Coratelli P. Acute renal failure during intermittent rifampicin therapy. Nephron 1973;10:256-61.

6.Lim CS, Jung YC, Lee SG, Ahn CR, Han JS, Kim SG, et al. Rifampin induced rapidly progressive glomerulonephritis. Korean J Nephrol 1998;17:503-9.

7.Covic A, Golea O, Segall L, Meadipudi S, Munteanu L, Nicolicioiu M, et al. A clinical description of rifampicin-induced acute renal failure in 170 consecutive cases. J Indian Med Assoc 2004;102;20,22-5.

8.Prakash J, Kumar NS, Saxena RK, Verma U. Acute renal failure complicating rifampicin therapy. J Assoc Physicians India 2001;49:877-80.

9.Muthukumar T, Jayakumar M, Fernando EM, Muthusethupathi MA. Acute renal failure due to rifampicin: a study of 25 patients. Am J Kidney Dis 2002;40:690-6.

10.

10.Islek I, Muslu A, Totan M, Gok F, Sanic A. Henoch- Shönlein purpura and pulmonary tuberculosis. Pediatr Int 2002;44:545-6.

11.

11.Chan HS, Pang J. Vasculitis in tuberculous infection. Chest 1990;98:511.

12.

12.Pacheco A. Henoch-Shönlein vasculitis and tuberculosis. Chest 1991;100:293-4.

13.

13.Washio M, Nanishi F, Onoyama K, Fujii K, Ohchi N, Fujishima M. Recurrence of Henoch Shönlein purpura nephritis associated with tuberculous pleuritis. Nippon Jinzo Gakkai Shi 1988;30:1087-9.

14.

14.Kitamura H, Shimizu K, Takeda H, Tai H, Ito Y, Fukunaga M. A case of Henoch-schönlein purpura nephritis in pulmonary tuberculosis. Am J Med Sci 2007;333:117-21.

15.

15.Chan CH, Chong YW, Sun AJ, Hoheisel GB. Cutaneous vasculitis associated with tuberculosis and its treatment. Tubercle 1990;71:297-300.

16.

16.Poole G, Stradling P, Worlledge S. Potentially serious side effects of high-dose twice-weekly rifampicin. Br Med J 1971;3:343-7.

바로가기메뉴

Article Contents

Vol.65 No.2

A Case of Henoch-Shönlein Purpura Caused by Rifampin

Abstract

Reference

Tuberculosis & Respiratory Diseases